ZeMac histoanalys AB

ABIn liquidation

Org 5568292170Research and experimental development on biotechnology · NACE 7211Est. 20101 employees

Overview Financials People & ownership Related companies

ZeMac histoanalys AB is a Swedish AB, operating in the Bioteknisk forskning och utveckling sector. Incorporated in 2010, the company has 1 employee and reported revenue of SEK 471K in its latest annual filing.

Revenue 2021

SEK 471K

-8% vs 2020

EBITDA margin

2.1%

+109% vs 2020

Equity ratio

-2.6%

Financial strength

Net profit 2021

SEK 11K

+109% vs 2020

EBITDA — year on year

SEK millions

Key figures

Annual report 2021

Revenue	SEK 471K	-8%
EBITDA	SEK 10K	+109%
Net profit	SEK 11K	+109%
Total assets	SEK 155K	+32%
Equity	SEK -4K	+75%
Employees	1	—

Contact

Address

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of ZeMac histoanalys AB?

ZeMac histoanalys AB is registered with Bolagsverket / SCB under Org 5568292170.

What is the revenue of ZeMac histoanalys AB?

ZeMac histoanalys AB reported revenue of SEK 471K in 2021.

How many employees does ZeMac histoanalys AB have?

ZeMac histoanalys AB employs 1 people as of the latest annual report.

Who is the CEO of ZeMac histoanalys AB?

Leif Gustav Andersson is External Signatory of ZeMac histoanalys AB, in role since 2022.

Who is the chairman of ZeMac histoanalys AB?

Baris Sagici chairs the board of ZeMac histoanalys AB, in role since 2020.

ZeMac histoanalys AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on ZeMac histoanalys AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on ZeMac histoanalys AB